Literature DB >> 3207321

Medical treatment of stomal ulcers.

A Hjortrup1, P Kjersgaard, J Bredesen.   

Abstract

Thirty-five patients with anastomotic ulcer after gastric resection for benign ulcer disease were treated with sucralfate (Antepsin) and endoscopically controlled over a 6-month period after termination of the medical treatment. The healing frequency of 75% makes this model a suitable alternative in the treatment of stomal ulcers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207321      PMCID: PMC2498617     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  8 in total

Review 1.  Recurrent peptic ulcer.

Authors:  B E Stabile; E Passaro
Journal:  Gastroenterology       Date:  1976-01       Impact factor: 22.682

2.  Comparison of sucralfate with cimetidine in the short-term treatment of chronic peptic ulcers.

Authors:  I N Marks; J P Wright; M Denyer; J A Garisch; W Lucke
Journal:  S Afr Med J       Date:  1980-04-12

Review 3.  Recurrent ulcer.

Authors:  E Amdrup
Journal:  Br J Surg       Date:  1981-10       Impact factor: 6.939

4.  Cimetidine treatment of recurrent ulcer.

Authors:  J G Stage; F W Henriksen; H Kehlet
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

5.  Reoperation for recurrent peptic ulcer.

Authors:  P Pietri; F Gabrielli; G Pellis
Journal:  Int Surg       Date:  1983 Oct-Dec

6.  Pitfalls in the diagnosis of recurrent ulceration after surgery for peptic ulcer disease.

Authors:  F Mosiman; I A Donovan; J Alexander-Williams
Journal:  J Clin Gastroenterol       Date:  1985-04       Impact factor: 3.062

7.  A multicenter, double-blind trial of sucralfate and placebo in duodenal ulcer.

Authors:  G G McHardy
Journal:  J Clin Gastroenterol       Date:  1981       Impact factor: 3.062

8.  Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial.

Authors:  F Martin; A Farley; M Gagnon; D Bensemana
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.